Switzerland· 56310001
Relestat, Augentropfen
A other antiallergics product containing epinastini hydrochloridum, registered in Switzerland by AbbVie AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 2 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Epinastini hydrochloridum is registered in 2 of 19 countries.
Countries holding a registration under ATC S01GX (other antiallergics), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 1 of them publish a price we can compare per daily dose
Epinastini hydrochloridum · ATC S01GX
2 / 19 countries
- Ireland
- Switzerlandprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- epinastini hydrochloridum
- Manufacturer
- AbbVie AG
- Country
- Switzerland (CH)
- ATC code
- S01GX
- ATC class
- Other antiallergics
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680563100015Tropffl 5 mlCHF 17
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Epinastini hydrochloridum in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomRelestat 500micrograms/ml eye dropsAbbVie Ltd
- CzechiaPURIVISTAbbVie s.r.o., Praha
- SpainRELESTAT 0,5 mg/ml COLIRIO EN SOLUCIONAbbvie Spain, S.L.U.
- FinlandRelestatAllergan Pharmaceuticals Ireland
- FrancePURIVIST 0,5 mg/ml, collyre en solutionABBVIE
- IrelandRelestat, 0.5 mg/ml, eye drops, solutionAbbVie Limited
- NetherlandsRelestat, oogdruppels, oplossing 0,5 mg/mlAbbVie B.V.
- PolandRelestatAbbVie Sp. z o.o.
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Belgium · Relestat
- Czechia · Purivist
- France · Purivist
- United Kingdom (Northern Ireland) · Relestat
- Greece · Optallerg, Relestat
- Hungary · Relestat
- Ireland · Relestat
- Italy · Relestat
- Luxembourg · Relestat
- Netherlands · Relestat
- Portugal · Relestat
- Sweden · Relestat
- Slovakia · Purivist
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d7e643ac-f3a9-43c9-8452-dc47367bb6f9 GET /v1/drugs/d7e643ac-f3a9-43c9-8452-dc47367bb6f9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "epinastini hydrochloridum 0.5 mg",
"valid_from": "2005-02-01",
"limitations": null,
"galenic_form": "Gtt Opht 0.05 %",
"therapeutic_area": null,
"sl_inclusion_date": "2005-02-01",
"self_retention_pct": 10
}See everything about epinastini hydrochloridum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.